The absorption and metabolism of phytogenic feed additives in poultry is studied related to the metabolism and deposition of their main compounds in tissues intended for food production. Fifty-six non-sexed Ross 308 broilers were allocated to seven dietary treatments and fed a diet containing graded levels of thyme (Thymus vulgaris L.) essential oil (EO) (0, 0.01, 0.02, 0.03, 0.04, 0.05, 0.1%, w/w). Thymol concentration was measured in plasma, liver, kidney and breast muscle tissue using solid phase micro-extraction followed by gas chromatography/mass spectrometry. We found the highest concentrations of thymol in kidney and plasma, and the lowest in breast muscle and liver. Thymol content in plasma and kidney significantly increased when 0.05 and 0.1%, w/w, EO and in liver and breast muscle only when 0.1%, w/w, EO was added to the diet (p<0.05). Our results indicate intensive metabolism of thymol in liver and its accumulation in kidney tissue. We confirm low deposition of thymol in the muscle tissue. It is necessary to keep in mind the selection of a sufficient concentration of EO in the feed additive for animals without the risk of thymol residues in edible tissues.
In recent years, herbs and herbal products have been increasingly incorporated in poultry diets to stimulate the effective use of feed nutrients and consequently to improve feed efficiency. Phytogenics are a group of natural non-antibiotic growth promoters used as feed additives derived from herbs, spices and plant extracts, partly in the form of essential oils (EO) [1] . Phytogenic feed additives enhance productivity through the improvement of digestibility, nutrient absorption and reduction of pathogens in the animal gut. Beneficial properties of phytogenic compounds arise from their bioactive molecules (e.g. carvacrol, thymol, cineole, linalool, anethole, allicin, capsaicin) [2] .
The beneficial effects of the new generation of feed additives for animal production have been well documented [3] . However, insights into the precise mechanisms of their modes of action and aspects of application are still lacking.
Pharmacokinetics of most natural compounds, such as thymol, have not yet been investigated sufficiently [4] . The pharmacokinetics of plant compounds is closely related to their deposition in animal tissues intended for consumption, so it is important to find out the concentration of EO which can improve animal health without creating any consumer health risks.
Investigations of the metabolic fate of phenol derivatives have demonstrated that these compounds are rapidly absorbed from the gastrointestinal tract. They are mainly conjugated with sulfate and glucuronic acid and excreted in the urine [5] [6] [7] . At high doses the metabolic capacity for conjugation of the organism is exceeded and alternative metabolic routes may be used, including hydroxylation of the phenol ring (to quinol) and oxidation of the side-chains, leading to the production of reactive metabolites (e.g. quinones, catechols) [8] . It is necessary to keep in mind a sufficiently high dietary concentration of the EO used as feed additive for animals, and to define available levels for improving their health status.
The main objective of our investigation was to determine thymol (the main component of Thymus vulgaris essential oil) concentrations in plasma and tissues of broiler chickens. We focused our attention on thymol concentration in liver, kidney and muscle tissue, as well as on its concentration in blood plasma after the consumption of the feed with different amounts of thyme EO.
The growth performance of broilers in the present trial was not influenced by any concentration of thyme EO in the diet. The birds' average slaughter weight at the end of the experiment was 2038 ± 84.3 g, and all were in good health. The average weight gain was 55.1 ± 1.5 g/day per bird, the average feed intake was 79.0 ± 2.8 g/ day per bird, and the feed conversion ratio was 1.4 ± 0.03. Thymol content in feed when different concentrations of thyme EO were added to the diet increased from 13.7 to 373.6 µg/g DM. Thymol content in plasma and kidney significantly increased when 0.05%, w/w (plasma 455 ± 95.3 ng/mL, kidney 808 ± 118.3 ng/g) and 0.1%, w/w (plasma 850 ± 37.0 ng/mL, kidney 1174 ± 246.5 ng/g) thyme oil was added to the diet in comparison with groups of birds with lower EO concentrations in the feed (p<0.05). Thymol content in liver significantly increased in the group with 0.05%, w/w, EO concentration in the feed in comparison with 0.01%, w/w, EO in the diet (p<0.05), and, in the group fed with 0.1% EO in the diet, the thymol content was significantly higher than in all other groups (p<0.05). Thymol content in breast muscle significantly increased in the birds fed 0.1%, w/w, EO addition to their diet in comparison with all other groups with lower EO concentrations in the diet (p<0.05, Table 1 ).
The term "antioxidant" is usually understood as a chemical which could eliminate oxidative stress by removing intracellular reactive oxygen species and by this way could improve animal health. However, the complexity of oxidative stress and the defence system seems to be more complicated [9] . So, there is a question: how Table 1 : Thymol content in feed (µg/g DM), plasma (ng/mL) and tissues (ng/g).
Data are presented as mean ± standard deviation (means of four samples per one group, each pooled from two chickens). a-c Means within the same row which do not share a common superscript are significantly different (p<0.05). DM-dry matter. *Thymol content in the final feed mixtures. much of an antioxidant is optimal? According to scientific studies it is necessary to keep in mind that high doses of some antioxidants may block their beneficial effect on some physiological processes and moreover could be toxic [10] . Recent studies show that quenching of oxygen radicals may involve effecting the expression of multiple genes encoding antioxidant enzymes. It is possible that the antioxidant properties of the molecule itself might be of minor importance as it occurs in the organism at very low levels, but it may induce the gene expression of antioxidant enzymes in the cell [11] .
Compounds derived from plant feed additives are absorbed in the digestive tract and transported via blood circulation to tissues. Phenolic substances in the animal organism undergo biotransformation resulting in more hydrophilic compounds. It is proposed that conjugates originating from biotransformation of the phenolic compounds thymol and hydroxytyrosol are transported to tissues where their deconjugation could occur and the compound released from bonds could be responsible for the biological effect [4, 12] . Researchers even assume that in the case of the plant compound hydroxytyrosol erythrocytes carry its conjugates [13] . These authors suggest that conjugates of hydroxytyrosol might be hydrolysed intracellularly inside the erythrocytes and by this mechanism protection against cell oxidative damage could be performed. Red blood cells could play an important role in the bioavailability of circulating phenols and their metabolites [13] . According to [14] , glucuronide conjugates of quercetin function not only as detoxified metabolites, but also as anti-oxidative metabolites and precursors of bioactive aglycone. Taking together these suggestions, the concentration of plant compounds reached in blood could be a factor influencing their beneficial biological activity in the animal.
In the case of thymol its free form (unmetabolised) could not be detected in plasma, but thymol conjugates originating from biotransformation in humans and animals have been detected. The presence of thymol sulfate was detected in human plasma after ingestion of a single dose of a Bronchipret ® TP tablet containing 60 mg of primrose dry extract (6.0-7.0:1; extracted by ethanol 47% (v/v)) and 160 mg of thyme dry extract (5.9-10.0:1, extracted by ethanol 50% (m/m)), which was equivalent to 1.08 mg of thymol [4] . Thymol glucuronide was found for the first time in rat plasma after a single oral dose of 1.5 g thyme extract to animals containing 44.32 µM of thymol [15] . The presence of thymol in blood plasma after enzymatic cleavage of the conjugates was detected in plasma of horses after administration of Bronchipret® TP tablets with thymol content about 15 mg (thymol in plasma ranged from 62.4 to 315.9 ng/mL) [16] , broiler chickens fed thyme herb (thymol concentrations in feed 5-55 mg/kg, in plasma 47.3-412.2 ng/mL) [17] and pigs fed with the feed additive Biomin ® P.E.P 1000 (essential oils blended from oregano, anise and citrus peels; thymol detected in plasma was 15.4 ng/mL) [18] .
In our study thymol in plasma was also analysed after enzymatic hydrolysis of thymol sulfate and thymol glucuronide. Thymol released enzymatically from the chemical bonds could be detected in blood plasma from all experimental groups (90 ± 15.9 -850 ± 37.0 ng/mL). Thymol concentration significantly increased after addition of 0.05%, w/w, and 0.1%, w/w, of thyme EO to the diet (Table 1) . This enhancement could be due to the increased absorption of thymol in the digestive tract. Small lipophilic molecules can be easily absorbed in the gastrointestinal tract [19] . Nevertheless, absorption of plant compounds can differ in relation to their chemical structure, the affinity to efflux proteins localized in enterocytes, and the enzymatic activity of gut microbiota [20, 21] . The mechanism of plant-derived compound absorption in the stomach and intestines of animals needs to be deeply investigated since this process can influence their bioavailability.
Supplementation of 0.05% and 0.1%, w/w, of thyme EO led to significantly lower concentrations of plasma thymol in comparison with kidney thymol (Table 1 ). This phenomenon could be caused by the interaction between plant compounds and blood cells. It has been demonstrated that polyphenols can bind to erythrocytes whilst hydrolysis of polyphenol and flavonoid metabolites can occur inside erythrocytes, macrophages and neutrophils [13, [22] [23] [24] . Taking together these findings, the possible binding of thymol as a plantderived phenol to erythrocytes and the possible presence of thymol metabolites in blood cells represent potential influences on the amount of thymol in blood plasma. Hence, the real thymol concentrations in blood could be higher than the amounts found in plasma in the current experiment.
Significantly increased thymol concentrations in the kidney of animals receiving 0.05 or 0.1%, w/w, EO addition point to the accumulation of thymol in the kidney. This accumulation can be related to the role of kidney in metabolism and elimination of phenolic compounds since intensive glucuronidation of phenolic compounds in human kidney microsomes was suggested [4, 25] .
Generally, the high thymol amounts in the kidney observed in our experiment indicate the important role of the kidney in the accumulation of phenols. According to [26] , birds caudal mesenteric vein drains lower intestines and carries blood to kidneys. We can suppose that the amount of thymol reaching the caudal digestive tract could be absorbed through the intestine and carried directly to the kidney.
In general, conjugated metabolites are water soluble allowing them to be excreted via the kidneys. Glucuronide and sulfate conjugates can be excreted in urine, but excretion via bile is not excluded. Based on the significantly higher concentrations of thymol in the kidney in our experiment, we speculate about the metabolism of thymol in the kidney and its renal excretion. The renal portal system in birds is directly connected to hepatic portal circulation and it is hypothesised that kidneys could assist the liver with some features [27] . The generally high contribution of the kidneys during biotransformation [28] , glucuronidation of various compounds [29] and hypothesized glucuronidation of thymol in the kidney [4] accord with our suggestion that renal tissue is involved to the biotransformation and elimination of thymol. Our results are in agreement with those of [18] , who detected concentrations of thymol and carvacrol in pig kidney after supplementation of the phytobiotic feed additive Biomin ® P.E.P 1000, but not in the liver. According to all these results, the accumulation, as well as allowed metabolism of plant compounds in kidneys cannot be overlooked. Significantly higher concentrations of thymol in liver were observed in our experiment only at the highest level of thyme EO addition in comparison with all other experimental groups. Generally, in all experimental groups, the concentration of thymol in the liver represented 8-16% of the thymol concentration found in the kidney and approximately 15-24% of thymol detected in blood plasma. This relatively low proportion of thymol found in the liver might indicate intensive metabolism and excretion of thymol from the liver. The findings of [30] confirmed significantly increased activity of biotransformation enzymes in the liver due to thyme and its components (thymol, carvacrol) in mice. The fact that the liver can respond and adapt to plant compound concentrations in the diet may be related to the intensive metabolism of these compounds and fast excretion from the liver. It is possible that thymol is quickly metabolised in the liver and afterwards hydrophilic conjugates are readily transported to the kidneys. Relatively stable low concentrations of thymol in the liver could be caused by this mechanism.
The influence of orally-administered plant additives on animal health is related to their bioavailability. From the pharmacological point of view, bioavailability is the fraction of the compound (drug) reaching the systemic circulation; what is important for the compound to achieve its intended target [31] . In relation to the significant increase of thymol in plasma and kidney in the birds fed the 0.05%, w/w, EO supplementation in comparison with the experimental groups with lower addition of thyme EO in our experiment, an increased bioavailability of thymol in that group can be assumed. This suggestion may be supported by the results of the study by [32] , where the addition of 0.05% thyme EO to the diet of rabbits significantly increased total antioxidant status in plasma.The deposition of phytochemicals derived from plant feed additives in animal muscle tissue is not fully understood yet. Despite the fact that the accumulation of EO compounds is unlikely due to fast biotransformation and elimination, a longer experimental period with continuous feeding of the additive can cause residues in tissues [33] . In the case of our findings, a significant increase in thymol levels in breast muscle was observed with the highest thyme EO supplementation ( Table 1 ). The deposition of drugs, xenobiotic or bioactive components in tissues may be related to the presence of uptake and efflux transporters localised in the cells. The accumulation of compounds in tissues is not only limited to the ability to enter the cell but also by the opportunity to leave it [34] . The expression of uptake and efflux transporters was demonstrated by [35] on the sarcolemmal membrane of muscle tissue. However, hydrophilic conjugated compounds resulting from biotransformation such as thymol glucuronide or thymol sulfate may require transporter proteins to cross the biological membranes, whereas small lipophilic molecules such as thymol can pass through by passive diffusion. Since tissues have the capacity to regulate efflux transporters, and biotransformation enzymes in cells can modify compounds to the substrates of transporters, these mechanisms may act as factors influencing deposition of bioactive compounds in tissues [34] . The pore size in the capillary membranes of the tissues can also influence the penetration of a compound into a certain tissue depending on the molecular weight and physicochemical properties of the molecules [19] . All these circumstances together can have an impact on thymol and thymol metabolites deposition in edible tissues in the animal organism. The low thymol concentrations in breast muscle found in all experimental groups in our study may be due to the low penetration or high activity of efflux transporters in breast muscle tissue. Low concentration of thymol was also observed by [17] after addition of 1% of Thymi Herba (thymol 55 mg/kg) to the diet of broiler chickens, when only traces of thymol were detected in the muscle tissue.
Our results suggest that thymol, the main component of T. vulgaris EO, is absorbed in the digestive system and transported to tissues, where its biological activity and/or biotransformation could occur, but thymol content in plasma and tissues does not correlate with its intake. The highest thymol content in kidney might point to the intensive thymol accumulation in kidney and contrary the low thymol content in liver could indicate the high metabolic activity of this tissue. In accordance with our findings we confirm low deposition of thymol in the muscle tissue of broiler chickens, so that the consumption of this plant bioactive compound by humans by this way appears to be negligible. The present study shows that it is necessary to establish the appropriate thyme EO concentration in animal feed without the risk of thymol residues in edible tissues.
Experimental

Animal care and use:
The experiment was carried out in accordance with the established standards for the use of animals. The protocol was approved by the Ethical Commission of the Institute of Animal Physiology, Slovak Academy of Sciences in Košice, Slovakia and by Slovakian governmental authority (Č.k. RO-820/10-221).
Experimental design and housing:
A total of 56 one-day old nonsexed Ross 308 hybrid broilers were randomly divided into 7 dietary treatments of 8 birds each. All cages were placed in the same room in which the ambient temperature was controlled during the experiment. The chickens were reared with a lighting regimen of 23 h light and 1 h dark. The initial room temperature 32-33°C was reduced during the first 3 weeks weekly by 3°C to a final temperature of 23°C. All birds had free access to water and feed. Feed intake was measured daily and body weights were measured once a week. At the age of 4 weeks, 8 chickens from each treatment group were sacrificed. Feeding: Appropriate diets for the requirements of growing broilers at the respective age were used during the whole experiment. The composition and nutrient contents of the broiler diet are given in Table 2 . Dry matter content, ash and crude protein were measured using standard procedures recommended by the AOAC [36] . All animals were fed with the same basal diet. Birds from each pen were assigned to 1-7 treatments that differed in the thyme oil concentration (0, 0.01, 0.02, 0.03, 0.04, 0.05 and 0.1%, w/w). An 80% ethanolic solution of appropriate EO concentration was added to the feed (1%, w/w). An ethanolic solution with diluted 1548 Natural Product Communications Vol. 11 (10) 2016
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essential oil was added to the feed by spraying and subsequent blending with the feed using method ana partes.
Sampling: Blood was collected into heparinized tubes. Plasma was obtained after centrifugation at 1180 x g for 15 min and frozen at -70°C until thymol analysis. Samples of liver, kidney and muscle tissues for thymol analysis were collected and stored at -70°C. Samples for gas chromatography/mass spectrometry (GC/MS) analysis were pooled from each of 2 animals in each group; finally, four samples per one group were analyzed. Feed intake was recorded daily, and body weights were recorded once a week.
High performance liquid chromatography (HPLC) analysis of thymol in thyme oil:
HPLC analyses were performed using a liquid system Ultimate 3000 (Dionex, Sunnyvale, CA, USA) equipped with a reverse phase column C18 Kinetex (150 × 4.6 mm, 2.6 µm) (Phenomenex, Torrance, CA, USA). The chromatographic conditions were set according to [37] . The mobile phase consisted of acetonitrile:water (50:50) and isocratic elution, and column temperature was kept at 30°C during analysis. Elution was performed at a flow rate of 1.0 mL/min and the injection volume of 10 µL of sample was directly injected into the HPLC system. The compounds were detected at 277 nm and the peak at 6.1 min (thymol) was quantified. Standard solutions were prepared in the range 15-50 µg/mL and calibration curves were constructed with linearity R 2 = 0.989. Each sample of thyme oil (10 mg) was diluted in 100 mL solution of acetonitrile:water (80:20). Five samples of EO were prepared and each one was injected 3 times. Quantification results showed 47.8 ± 1.4% thymol in T. vulgaris EO. All standards (analytical grade) and solvents (HPLC grade) were purchased from Sigma Aldrich, Steinheim, Germany, and ultrapure water was obtained from Werner EASY pure II UV/UF (Wilhelm Werner GmbH, Leverkusen, Germany). Thyme EO was obtained from Hanus, Nitra, Slovakia. Thymol evaporation and its amount in feed: Evaporation of thymol was analysed by HPLC after mixing the 0.05% thyme EO to the feed. Sample preparation was according the procedure described by [38] and [39] . Two g of feed mixed with thyme EO was weighed into a 40 mL test tube to which 5 mL of diethyl ether and 10 mL of ethanol was added. Thymol was extracted in an ultrasonic bath for 45 min at room temperature. Samples were centrifuged (1670 x g for 7 min) and supernatant was collected. After a second addition of 10 mL of ethanol to the test tubes, the samples underwent a second centrifuging and ultrasonic bath. Both supernatants were decanted into 25 mL volumetric flasks and filled up to 25 mL with ethanol. The amount of thymol was relatively stable for 3 days after being mixed in feed. After that the thymol concentration tended to decrease. Based on these results we mixed the feedstuff every third day with the concentrations 0.01, 0.02, 0.03, 0.04, 0.05 and 0.1% of EO ( Figure 1) . Moreover, the thymol amount in feedstuff after addition of appropriate EO concentrations was evaluated by the method described above at the beginning of the experiment.
Sample preparation using solid phase microextraction (SPME)
Plasma samples: Concentrations of thymol in plasma were analysed with SPME-GC-MS, as described in previous studies [16, 17, 40] . One mL plasma samples were thawed at room temperature, and then 40 µL 0.58 M acetic acid (Carl Roth GmbH + Co. KG, Karlsruhe, Germany) and 100 µL of cleaving enzyme βglucuronidase from Helix pomatia Type HP-2, aqueous solution, ≥100,000 units/mL (Sigma-Aldrich, St Louis, MO, USA) were added into the vial with sample. This mixture was incubated in a 10 mL vial (Agilent, Santa Clara, CA, USA) in a water bath at 37°C for 30 min. β-Glucuronidase was needed to cleave thymol from its glucuronide and sulfate, since only free thymol can be detected in the GC-system. After the thymol cleavage, 1 g of sodium chloride (Merck, Darmstadt, Germany), 100 µL of 85% phosphoric acid (Carl Roth GmbH + Co. KG, Karlsruhe, Germany), 50 µL of o-cresol (Sigma-Aldrich, St Louis, MO, USA) internal standard solution (40 mg of o-cresol was dissolved in 2 mL of methanol and made up to 100 mL with distilled water to produce a stock solution which was diluted with distilled water 1:10) and 50 µL distilled water were added to the sample vial. Afterwards, the vial was sealed with a polytetrafluoroethylene/butyl septum and cap (Agilent, Santa Clara, CA, USA) and vortexed. Then the SPME fiber (65 µm polydimethylsiloxane/divinylbenzene fibre, Supelco, Bellefonte, PA, USA) was injected through the septum into the vial and exposed at 80°C for 35 min to the headspace of the sample. Finally the fiber was desorbed at 250°C for 5 min in the injection port of the GC/MS system. Plasma from the control group broiler chickens was used as matrix for generating a calibration curve. Stock solution for calibration was prepared from 40 mg of thymol (Applichem, Darmstadt, Germany) dissolved in 2 mL of methanol and filled up to 100 mL with distilled water. Aliquots (50 µL) of appropriate dilutions of thymol stock solution were added to the control group plasma to create a calibration curve with concentrations of 100, 200, 400, 800 and 2000 ng/mL thymol. Thymol concentrations in samples and the calibration curve were calculated as ng/mL plasma.
Kidney, liver and muscle samples:
Thymol concentration in tissues was measured according to the procedure described by [17, 18] . A 1 g portion of chopped tissue was weighed and subsequently homogenized with 3 mL of distilled water in a 25 mL vial using a tissue homogenizer (Ultra-Turrax TP 18-10, IKA, Staufen, Germany) for a few min. One hundred µL of 0.58 mol/L acetic acid was added affording an optimal pH for the enzymatic reaction of deconjugation. Subsequently, 100 µL β-glucuronidase was added and all compounds were incubated at 37°C for 30 min. Thereafter 1 g of sodium chloride, 100 µL of 85% phosphoric acid, 50 µL of o-cresol internal standard solution (prepared as mentioned above, but for liver and muscle internal standard solution was diluted with distilled water 1:5) and 50 µL distilled water were added to each sample after the first incubation. Afterwards the samples were airtight closed with a septum and cap and incubated at 80°C for 35 min with fiber inserted through the septum, as mentioned above.
For the kidney samples calibration curve, 50 µL of thymol solution was added instead of water to the vials with samples from the control group. Stock solution of thymol (40 mg of thymol dissolved in 2 mL of methanol and filled up to 100 mL with distilled water) was diluted to give the respective concentrations 100, 200, 400, 800, 2000 ng/g of thymol in samples. For liver and muscle samples the thymol solution for calibration was prepared from 10 mg of thymol dissolved in 1 mL of methanol and filled up to 50 mL with
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GC/MS analysis:
Detection and quantification of thymol in experimental samples of plasma and tissues were carried out using a GC/MS (type HP 6890 GC) coupled with a 5972 quadrupole massselective detector (Agilent Technologies GmbH, Wilmington, DE, USA). The column (30 x 0.25) used for the analysis was coated with 0.25 µm HP-5ms. The flow rate of the carrier gas, helium, was 1.3 mL/min in constant flow mode. The temperature of the injector was set at 250°C, and the temperature of the transfer line to the mass-selective detector was 280°C. Fiber (SPME) with each sample was injected and desorbed in the injection port for 5 min with a split ratio of 1:1. Oven temperature was set at 60°C for 5 min, then programmed from 60°C to 120°C at 4°C/min, and further increased by 20°C/min up to 240°C. The main component of thyme EO (thymol) was detected according to its specific mass spectrum, retention time and Kovats index. The selective ion mode was used for the quantitative analysis of thymol. The mass fragments m/z 135 and m/z 150, as well as m/z 107 and m/z 108, were monitored as characteristics for thymol and o-cresol, respectively. Using the total current of these registered ions, plotting the peak area ratios of thymol to o-cresol against the thymol concentrations gave the calibration curves. The peak of thymol was detected around 19 min and the o-cresol internal standard peak occurred around 10 min in all samples. Good linearity was observed for plasma and tissue sample calibration curves with correlation coefficients in the range of R 2 = 0.9880 -0.9988.
Statistical analysis:
The results related to performance and thymol contents in plasma and tissues were statistically analyzed using onefactorial ANOVA with post hoc Tukey multiple comparison test (Graph Pad Prism; GraphPad Software, San Diego, CA, USA).
Results are presented as the mean values ± standard deviation. Significant differences were considered at p<0.05.
